First National Vaccine Law Conference: Papers and Proceedings

The First National Vaccine Law Conference: Papers and Proceedings contain manuscripts that reflect the spirit of the conversations and presentations featured at the National Vaccine Law Conference (NVLC), held in September of 2022.

Select a format

eBook:epub
ISBN: 9781639054152
In Stock
Price
$89.95
Best value
QTY
eBook:mobi
ISBN: 9781639054152
In Stock
Price
$89.95
Best value
QTY
International Order Inquiry

Product description

View a sample of this title using the ReadNow feature

The National Vaccine Law Conference (NVLC) is a discussion forum on all aspects of vaccines and the law, from clinical development through administration. The event's mission is to advance vaccine law as a field and strengthen laws that facilitate vaccine innovation, access, safety, and confidence. The First National Vaccine Law Conference: Papers and Proceedings captures and shares the thought leadership of conference organizers, speakers, and other vaccine law and policy experts. The topics covered in this book are central to current discussions of the First National Vaccine Law Conference. The Forward, written by Brian Dean Abramson, the conference's founder, and Montrece Ransom, the closing keynote speaker and co-editor, further frames the context of the meeting and this resulting book. It offers a tour of historical and current trends in vaccine law and regulation, intellectual property, equity, funding, access, vaccine passports, and more. The ten articles within the book cover a wide breadth of vaccine law issues, including vaccine hesitancy, religious exemptions, regulation, intellectual property, vaccine injury, self-administered vaccines, vaccine injury, self-administered vaccines, vaccine law and individual rights, and privacy and confidentiality laws.

eBooks, CDs, downloadable content, and software purchases are noncancelable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® for further legal research options. A valid subscription to Lexis+® is required to access this content.